XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
Sep. 30, 2020
USD ($)
$ / shares
Jun. 30, 2019
USD ($)
Sep. 30, 2021
USD ($)
segment
$ / shares
Sep. 30, 2020
USD ($)
$ / shares
Feb. 28, 2019
Accounting policies:            
Operating segments | segment       2    
Website development cost     $ 46,500      
Amortization and depreciation $ 8,875 $ 17,187   $ 26,614 $ 52,635  
Intangible, amortization expense 3,874 3,875        
Intangible, accumulated amortization 34,874 19,376   $ 34,874 $ 19,376  
Requisite period (in years)       three    
Expiration period       ten year    
Option vesting rights       25%    
Dividend yield       0.00% 0.00%  
Expected life       4 years 4 years  
Volatility rate minimum         77.00%  
Volatility rate maximum         85.00%  
Risk free interest rate, minimum       0.27% 0.22%  
Risk free interest rate, maximum       0.67% 1.66%  
Foreign currency transaction gain (loss) 66,967 $ 7,647   $ 22,384 $ 34,465  
Income tax benefit       (864,742) $ (836,893)  
Interest and penalties $ 0     $ 0    
Weighted average exercise price, outstanding warrants | $ / shares $ 2.96 $ 2.92   $ 2.96 $ 2.92  
Weighted average exercise price | $ / shares $ 2.70 $ 3.11   $ 2.70 $ 3.11  
Termination benefits            
Accounting policies:            
Expiration period       three    
Altamont Pharmaceutical Holdings, LLC            
Accounting policies:            
Noncontrolling interest, ownership (as a percent)           5.00%
Directors, upon re-election            
Accounting policies:            
Requisite period (in years)       one    
Media Content            
Accounting policies:            
Intangible, amortization expense       $ 11,624 $ 11,627